AZURE-HeFH

A breakthrough medication in tablet form for lowering LDL cholesterol in patients with familial hypercholesterolemia.

A randomized, double-blind, placebo-controlled Phase III clinical trial with parallel groups to evaluate the effect of AZD0780 (larovprovstat) on LDL cholesterol in patients with heterozygous familial hypercholesterolemia (HeFH)

Book
examination